• Clozapine in Schizophrenia Research: Protocols and Innovatio

  2026-08-03

  Unlock the unique potential of Clozapine as an atypical antipsychotic medication for advanced schizophrenia research. This article delivers actionable workflow enhancements, troubleshooting strategies, and practical insights—bridging molecular mechanisms with neuromodulation breakthroughs.

• Dasatinib Monohydrate in CML: Mechanistic Insight to Strateg

  2026-08-03

  This article bridges the mechanistic landscape of Dasatinib Monohydrate (BMS-354825) with strategic guidance for translational researchers tackling chronic myeloid leukemia (CML) and imatinib-resistant BCR-ABL inhibition. By synthesizing new evidence on neutrophil extracellular traps and kinase pathway modulation, the discussion highlights how APExBIO’s Dasatinib Monohydrate enables advanced modeling and resistance-busting workflows, while differentiating itself from standard product overviews.

• Ertapenem Sodium Salt: Precision Tool for Resistance Mechani

  2026-08-02

  Explore Ertapenem sodium salt as a research-grade, precision antibacterial agent for dissecting resistance mechanisms in Gram-positive and Gram-negative bacteria. This article delivers protocol insights and reference-driven guidance for advanced resistance modeling.

• Gut Microbiota Mediates PCN’s Protection in Sepsis Liver Inj

  2026-08-01

  This study reveals that the gut microbiota is essential for the hepatoprotective effects of the mouse PXR agonist pregnenolone-16α-carbonitrile (PCN) in sepsis-induced liver injury, acting via the YAP pathway. The findings highlight a gut-liver axis mechanism that may inform future strategies in hepatic detoxification studies and antifibrotic research.

• SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis

  2026-07-31

  This study demonstrates that pharmacological inhibition of SMYD2, using agents such as LLY-507, protects against cisplatin-induced renal fibrosis and inflammation in preclinical models. The findings highlight SMYD2 as a pivotal epigenetic regulator in chronic kidney disease progression, revealing new avenues for targeted intervention.

• SAR405 and the New Paradigm in Autophagy Modulation

  2026-07-31

  This article unpacks the mechanistic and strategic importance of SAR405 as a next-generation Vps34 inhibitor. It synthesizes emerging evidence on AMPK-ULK1 signaling, provides actionable guidance for translational researchers, and situates SAR405 at the forefront of autophagy and vesicle trafficking research. The discussion bridges mechanistic detail and practical workflow design, setting a new standard for strategic tool selection in cancer and neurodegenerative disease models.

• Fluorene-9-Bisphenol Inhibits GPER1: Mechanism and Neuroblas

  2026-07-30

  This study elucidates the mechanism by which fluorene-9-bisphenol (BHPF), a BPA substitute, acts as an inhibitor of the G protein-coupled estrogen receptor 1 (GPER1) in human neuroblastoma cells. By integrating molecular dynamics, mutagenesis, and cellular assays, the research reveals BHPF's direct antagonistic interaction with GPER1, providing new insights into endocrine disruption and neurodegenerative risk assessment.

• Substrate Specificity of GOB-38 MBL in Elizabethkingia anoph

  2026-07-30

  This study characterizes the biochemical properties and substrate range of the GOB-38 metallo-β-lactamase in Elizabethkingia anophelis, revealing its role in broad-spectrum antibiotic resistance and its unique active site composition. These findings enhance our understanding of multidrug resistance transfer between pathogens and inform future β-lactamase assay development.

• RSV NS3 Modulates Host Signaling to Balance Pathogenicity

  2026-07-29

  This study uncovers how Rice stripe virus (RSV) NS3 protein manipulates host kinase pathways to dynamically regulate viral pathogenicity and transmission. By detailing the phosphorylation-dependent interactions between NS3 and OsSnRK3.25, the research provides mechanistic insight into co-survival strategies in virus-plant-vector systems, with broad implications for plant virology and host-pathogen adaptation.

• Lactate-Driven HMGB1 Modification and Exosomal Release in Se

  2026-07-29

  The reference study uncovers how elevated lactate directly promotes both lactylation and acetylation of HMGB1 in macrophages, facilitating its exosomal release during polymicrobial sepsis. These mechanistic insights highlight lactate and its signaling pathways as potential therapeutic targets to modulate inflammatory endothelial dysfunction in sepsis.

• D-Luciferin Potassium Salt: Optimizing In Vivo Bioluminescen

  2026-07-28

  D-Luciferin (potassium salt) transforms real-time in vivo bioluminescence imaging with its unmatched water solubility and assay-ready purity. This guide demystifies experimental workflows, performance gains, and troubleshooting strategies for researchers tracking tumor cells or quantifying gene expression, with actionable takeaways from the latest reference study.

• USP7–PKM2 Axis Regulates Macrophage Polarization in SAP

  2026-07-28

  This study uncovers the pivotal role of ubiquitin-specific protease 7 (USP7) in modulating macrophage polarization and inflammation in severe acute pancreatitis (SAP) through pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. By integrating genetic and pharmacological approaches—including PKM2 inhibition—the authors provide mechanistic evidence for targeting immunometabolic pathways as a potential intervention strategy in SAP.

• Targeting BCL-XL and MCL-1 in Glioblastoma: Therapeutic Insi

  2026-07-27

  The reference study uncovers that glioblastoma (GBM) stem-like cells exhibit heightened expression of anti-apoptotic BCL-xL and MCL-1, conferring increased apoptotic priming and vulnerability to BH3-mimetic inhibitors. Sequential inhibition of these proteins yields robust anti-tumor responses, suggesting a new strategy for overcoming resistance in aggressive brain tumors.

• Indole Analogue Tc3 as a Pyroptosis Inducer in Hepatic Carci

  2026-07-27

  The referenced study introduces Tc3, an indole-based small molecule, as a potent inducer of gasdermin E-mediated pyroptosis in hepatic carcinoma. Through mechanistic and in vivo analyses, the research demonstrates Tc3’s ability to activate tumor immunogenicity and synergize with chemotherapy and immunotherapy, offering insights for novel combinatorial cancer strategies.

• Jasplakinolide: Actin Polymerization Inducer for Precision C

  2026-07-26

  Jasplakinolide empowers researchers to probe cytoskeletal architecture with nanomolar precision, enabling robust actin stabilization and dynamic imaging in live cells. This guide details optimal workflows, troubleshooting strategies, and how insights from chemical genetics studies refine cytoskeletal assay design.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page